Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways

Detalles Bibliográficos
Autores principales: Wang, Jie, Shi, Pingping, Teng, Huaixiang, Lu, Lixiang, Guo, Hailong, Wang, Xiuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004598/
https://www.ncbi.nlm.nih.gov/pubmed/35425703
http://dx.doi.org/10.3389/fonc.2022.819908
_version_ 1784686302058250240
author Wang, Jie
Shi, Pingping
Teng, Huaixiang
Lu, Lixiang
Guo, Hailong
Wang, Xiuqin
author_facet Wang, Jie
Shi, Pingping
Teng, Huaixiang
Lu, Lixiang
Guo, Hailong
Wang, Xiuqin
author_sort Wang, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-9004598
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90045982022-04-13 Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways Wang, Jie Shi, Pingping Teng, Huaixiang Lu, Lixiang Guo, Hailong Wang, Xiuqin Front Oncol Oncology Frontiers Media S.A. 2022-03-29 /pmc/articles/PMC9004598/ /pubmed/35425703 http://dx.doi.org/10.3389/fonc.2022.819908 Text en Copyright © 2022 Wang, Shi, Teng, Lu, Guo and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Jie
Shi, Pingping
Teng, Huaixiang
Lu, Lixiang
Guo, Hailong
Wang, Xiuqin
Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_full Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_fullStr Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_full_unstemmed Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_short Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways
title_sort corrigendum: lncrna dcst1-as1 promotes endometrial cancer progression by modulating the mir- 665/hoxb5 and mir-873-5p/cadm1 pathways
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004598/
https://www.ncbi.nlm.nih.gov/pubmed/35425703
http://dx.doi.org/10.3389/fonc.2022.819908
work_keys_str_mv AT wangjie corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT shipingping corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT tenghuaixiang corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT lulixiang corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT guohailong corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways
AT wangxiuqin corrigendumlncrnadcst1as1promotesendometrialcancerprogressionbymodulatingthemir665hoxb5andmir8735pcadm1pathways

Ejemplares similares